TMO
Thermo Fisher Scientific Inc
675.00$
-0.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 53.3% | 53.8% | 53.0% | 53.7% | 54.9% | 55.6% | 50.3% | 49.9% | 57.7% | 59.0% | 58.7% | 59.1% | |
| 46.7% | 46.2% | 47.0% | 46.3% | 45.1% | 44.4% | 49.7% | 50.1% | 42.3% | 41.0% | 41.3% | 40.9% | |
| 4.1% | 4.1% | 4.1% | 4.2% | 4.0% | 3.9% | 3.7% | 3.6% | 3.3% | 3.1% | 3.2% | 3.1% | |
| 29.0% | 27.2% | 27.2% | 26.3% | 24.9% | 24.1% | 21.5% | 17.4% | 15.9% | 20.1% | 20.0% | 16.3% | |
| 32.8% | 31.5% | 31.3% | 30.7% | 29.2% | 27.7% | 25.2% | 23.8% | 23.3% | 25.0% | 23.5% | 22.7% | |
| 13.9% | 14.7% | 15.6% | 15.6% | 15.9% | 16.7% | 24.5% | 26.3% | 19.0% | 16.0% | 17.9% | 18.2% | |
| 2.8% | 2.4% | 2.6% | 2.8% | 2.7% | 2.6% | 1.7% | 1.4% | 1.6% | 3.2% | 3.9% | 3.2% | |
| 12.4% | 11.4% | 11.1% | 11.6% | 13.4% | 15.9% | 22.4% | 22.5% | 17.1% | 14.7% | 16.3% | 16.3% | |
| 1.1% | -0.3% | 0.0% | 1.0% | 1.3% | 1.5% | 2.6% | 2.8% | 1.6% | -0.7% | 1.5% | 1.2% | |
| 11.2% | 11.6% | 11.1% | 10.6% | 12.1% | 14.5% | 19.8% | 19.7% | 15.5% | 14.0% | 14.8% | 15.1% | |
| 25.2% | 23.8% | 23.3% | 24.2% | 25.4% | 27.5% | 31.4% | 30.5% | 26.6% | 16.0% | 27.5% | 25.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.